Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells

Published:2016-11 Issue: Volume:Volume 11 Page:5823-5835
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Shi Dan,Liu Yan,Xi Ronggang,Zou Wei,Wu Lijun,Zhang Zhiran,Liu Zhongyang,Qu Chao,Xu Baoli,Wang Xiaobo

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. As4S4 nanoparticles promote effective terminal erythropoiesis in bone marrow mononuclear cells from patients with myelodysplastic syndromes;Nano Today;2023-10

2. Acid ground nano‐realgar processed product inhibits breast cancer by inducing mitophagy via the p53/BNIP3/NIX pathway;Journal of Cellular and Molecular Medicine;2023-08-23

3. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies;Journal of Hematology & Oncology;2023-06-23

4. Functional Nanorealgar Quantum Dots with Aggregation-Induced Emission Enhancement for Tumor Neovascular-Targeted Theranostics;Journal of Nanomaterials;2023-01-17

5. Role of Caveolin-1 in Sepsis – A Mini-Review;Frontiers in Immunology;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP